Adult mesenchymal stem cell ageing interplays with depressed mitochondrial Ndufs6

Mesenchymal stem cell (MSC)-based therapy has emerged as a novel strategy to treat many degenerative diseases. Accumulating evidence shows that the function of MSCs declines with age, thus limiting their regenerative capacity. Nonetheless, the underlying mechanisms that control MSC ageing are not we...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cell Death Dis
Autores principales: Zhang, Yuelin, Guo, Liyan, Han, Shuo, Chen, Ling, Li, Cheng, Zhang, Zhao, Hong, Yimei, Zhang, Xiaoxian, Zhou, Xiaoya, Jiang, Dan, Liang, Xiaoting, Qiu, Jianxiang, Zhang, Jinqiu, Li, Xin, Zhong, Shilong, Liao, Can, Yan, Bin, Tse, Hung-Fat, Lian, Qizhou
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738680/
https://ncbi.nlm.nih.gov/pubmed/33323934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-020-03289-w
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares